Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy
2 other identifiers
interventional
344
1 country
1
Brief Summary
We are proposing to evaluate the benefit of preoperative nutritional support with Impact Advanced Recovery in the most vulnerable group of elective gastrointestinal surgery patients who may experience a complication, esophagus and pancreas resections, and hypothesize that oral supplementation with 3 servings (0.75 L) Impact Advanced Recovery will reduce postoperative stay by 10-20% and reduce the incidence of major complications by 25%.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 26, 2007
CompletedFirst Posted
Study publicly available on registry
January 3, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2009
CompletedOctober 8, 2015
October 1, 2015
December 26, 2007
October 6, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative stay in days
Postoperative stay in hospital & 30 days
Secondary Outcomes (1)
Incidence of major complications
Postoperative stay in hospital & 30 days
Study Arms (2)
1
EXPERIMENTALSupplement: 3 servings/day of Impact Advanced Recovery in addition to regular food or any other supplements recommended or desired by patient or primary care/surgical team.
2
PLACEBO COMPARATORStandard Care: Food, beverages, or supplements as recommended or desired by patient or primary care/surgical team.
Interventions
Eligibility Criteria
You may qualify if:
- Male or female age 18 years or older of any race-ethnicity who will undergo an elective esophagectomy or pancreaticoduodenectomy.
- Surgery will be scheduled 5-7 days after consent date -
You may not qualify if:
- Surgery is urgent or emergent and/or patient would be unable to consume nutritional supplement for 5-7 days
- Patient is currently receiving enteral (tube) or parenteral (IV) nutritional support
- Patients with known pre-existing renal failure requiring a low protein diet
- Patient is unable to drink 3 servings/day of a liquid supplement -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin Hospital & Clinics
Madison, Wisconsin, 53792, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth A Kudsk, MD
University of Wisconsin School of Medicine & Public Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 26, 2007
First Posted
January 3, 2008
Study Start
April 1, 2007
Study Completion
October 1, 2009
Last Updated
October 8, 2015
Record last verified: 2015-10